Cedars Sinai 18th Annual Women and Ischemic Heart Disease Symposium 2024

20 $

+ Include: 18 videos + 9 pdfs, size: 4.37 GB

+ Target Audience: obstetrics & gynecology physician, cardiologist

Description

+ Include: 18 videos + 9 pdfs, size: 4.37 GB

+ Target Audience: obstetrics & gynecology physician, cardiologist

+ Sample video: contact me for sample video

+ Information:

Date & Location

Friday, April 12, 2024, 7:30 AM – 2:10 PM PST, Cedars-Sinai Medical Center, Los Angeles, CA

Target Audience
Specialties – Cardiology, Emergency Medicine, Endocrinology & Metabolism, Family / General Medicine, Internal Medicine, Obstetrics & Gynecology, Preventive Medicine
Professions – Nurse, Nurse (Advanced Practice NP CRNA CNM CNS), Physician, Physician Assistant
Overview

The 18th Annual Women and Ischemic Heart Disease Symposium will explore sex and gender-specific issues in women’s cardiovascular health, including prevention using life’s essential 8, cholesterol management, GLP RA for treatment of Obesity, Hormones, heart failure detection, diagnosis, and management, Postural Orthostatic Tachycardia Syndrome, and Coronary Microvascular Disease.

Objectives
  1. Identify the social determinants that can influence women’s health to more effectively communicate with patients about health-related conditions and behaviors
  2. Apply best practices in screening young women for heart disease and managing women with heart disease, obesity and diabetes
  3. Explore sex differences in medicine, including remote monitoring, adherence, and symptomatic conditions

 

+ Topics:

Agenda.pdf
CASES- Postural Orthostatic Tachycardia Syndrome Q&A.mp4
CASES- Postural Orthostatic Tachycardia Syndrome.mp4
CASES- Postural Orthostatic Tachycardia Syndrome.pdf
Coronary Microvascular Disease- Access to Diagnosis Q&A.mp4
Coronary Microvascular Disease- Access to Diagnosis.mp4
Coronary Microvascular Disease- Access to Diagnosis.pdf
Debate- GLP RA should be first line therapy for Treatment of Obesity 2.mp4
Debate- GLP RA should be first line therapy for Treatment of Obesity Q&A 2.mp4
Debate- GLP RA should be first line therapy for Treatment of Obesity.mp4
Debate- GLP RA should be first line therapy for Treatment of Obesity.pdf
Debate- Hormone Therapy and Cardiovascular Disease Q&A.mp4
Debate- Hormone Therapy and Cardiovascular Disease.mp4
Debate- Hormone Therapy and Cardiovascular Disease.pdf
Debate- Hormone Therapy Why When We Should Say YES.mp4
Dispelling the Myths- Women’s Cardiovascular Health Q&A.mp4
Dispelling the Myths- Women’s Cardiovascular Health.mp4
Dispelling the Myths- Women’s Cardiovascular Health.pdf
Keynote Lecture- Sex differences in HF – detection, diagnosis, and management Q&A.mp4
Keynote Lecture- Sex differences in HF – detection, diagnosis, and management.mp4
Keynote Lecture- Sex differences in HF – detection, diagnosis, and management.pdf
Prevention – Life’s Essential 8 Q&A.mp4
Prevention – Life’s Essential 8.mp4
Prevention – Life’s Essential 8.pdf
Somethings Old, Somethings New- Cholesterol Management in 2024 Q&A.mp4
Somethings Old, Somethings New- Cholesterol Management in 2024.mp4
Somethings Old, Somethings New- Cholesterol Management in 2024.pdf

Reviews

There are no reviews yet.

Be the first to review “Cedars Sinai 18th Annual Women and Ischemic Heart Disease Symposium 2024”

Your email address will not be published. Required fields are marked *